Class information for:
Level 1: BURNS TRAUMA CRIT CARE//MUTANT SELECTION WINDOW//ANTIINFECT DEV

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
4430 1714 32.4 75%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
434 15650 CHEMOTHERAPY-TOKYO//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//CEFEPIME

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BURNS TRAUMA CRIT CARE Address 42 32% 6% 107
2 MUTANT SELECTION WINDOW Author keyword 21 69% 1% 18
3 ANTIINFECT DEV Address 18 27% 3% 58
4 EXTENDED INFUSION Author keyword 17 75% 1% 12
5 PIPERACILLIN Author keyword 12 23% 3% 46
6 CONTINUOUS INFUSION Author keyword 10 13% 4% 67
7 TAZOBACTAM Author keyword 10 27% 2% 30
8 MEROPENEM Author keyword 10 14% 4% 63
9 AUGMENTED RENAL CLEARANCE Author keyword 9 64% 1% 9
10 ANTI INFECT DEV Address 8 37% 1% 18

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 MUTANT SELECTION WINDOW 21 69% 1% 18 Search MUTANT+SELECTION+WINDOW Search MUTANT+SELECTION+WINDOW
2 EXTENDED INFUSION 17 75% 1% 12 Search EXTENDED+INFUSION Search EXTENDED+INFUSION
3 PIPERACILLIN 12 23% 3% 46 Search PIPERACILLIN Search PIPERACILLIN
4 CONTINUOUS INFUSION 10 13% 4% 67 Search CONTINUOUS+INFUSION Search CONTINUOUS+INFUSION
5 TAZOBACTAM 10 27% 2% 30 Search TAZOBACTAM Search TAZOBACTAM
6 MEROPENEM 10 14% 4% 63 Search MEROPENEM Search MEROPENEM
7 AUGMENTED RENAL CLEARANCE 9 64% 1% 9 Search AUGMENTED+RENAL+CLEARANCE Search AUGMENTED+RENAL+CLEARANCE
8 MUTANT PREVENTION CONCENTRATION 6 37% 1% 13 Search MUTANT+PREVENTION+CONCENTRATION Search MUTANT+PREVENTION+CONCENTRATION
9 CUMULATIVE FRACTION OF RESPONSE 6 100% 0% 4 Search CUMULATIVE+FRACTION+OF+RESPONSE Search CUMULATIVE+FRACTION+OF+RESPONSE
10 ANTIBIOTIC DOSING 5 55% 0% 6 Search ANTIBIOTIC+DOSING Search ANTIBIOTIC+DOSING

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TARGET ATTAINMENT 50 84% 2% 27
2 INTRAVENOUS CIPROFLOXACIN 46 42% 5% 86
3 INTERMITTENT INFUSION 37 48% 3% 56
4 COMPLICATED INTRAABDOMINAL INFECTION 27 76% 1% 19
5 VITRO DYNAMIC MODEL 26 63% 2% 26
6 AUGMENTED RENAL CLEARANCE 23 55% 2% 29
7 OPTAMA PROGRAM 17 72% 1% 13
8 INTRAVENOUS LEVOFLOXACIN 17 100% 0% 8
9 DUAL INDIVIDUALIZATION PRINCIPLES 16 61% 1% 17
10 PREVENTION CONCENTRATION 15 67% 1% 14

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions 2014 24 137 55%
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug' 2004 329 36 56%
Pharmacokinetic issues for antibiotics in the critically ill patient 2009 154 143 38%
A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics 2009 69 55 65%
Application of antimicrobial pharmacodynamic concepts into clinical practice: Focus on beta-lactam antibiotics - Insights from the society of infectious diseases pharmacists 2006 71 32 84%
Clinical implications of antibiotic pharmacokinetic principles in the critically ill 2013 27 117 56%
Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review 2012 21 108 77%
Principles of antibacterial dosing in continuous renal replacement therapy 2009 49 105 71%
Application of fluoroquinolone pharmacodynamics 2000 177 48 50%
Prolonged infusion versus intermittent boluses of beta-lactam antibiotics for treatment of acute infections: a meta-analysis 2014 4 51 84%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BURNS TRAUMA CRIT CARE 42 32% 6.2% 107
2 ANTIINFECT DEV 18 27% 3.4% 58
3 ANTI INFECT DEV 8 37% 1.1% 18
4 MT AUBURN HOSP 7 25% 1.5% 26
5 ANTIBIOT UNIT 5 37% 0.6% 10
6 SETON HEALTHCARE FAMILY 4 75% 0.2% 3
7 GAUSE NEW ANTIBIOT 4 19% 1.1% 19
8 MED MED MICROBIOL PHARMACOL THER EUT 3 100% 0.2% 3
9 CLIN PHARMACOTHER Y 3 19% 0.9% 15
10 INFECT DIS PHARM 3 45% 0.3% 5

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000197559 POSTANTIBIOTIC EFFECT//POSTANTIBIOTIC SUB MIC EFFECT//POST ANTIBIOTIC EFFECT
2 0.0000180214 GEMIFLOXACIN//GEMIFLOXACIN MESYLATE//GARENOXACIN
3 0.0000164620 DORIPENEM//ERTAPENEM//MEROPENEM
4 0.0000161508 AMINOGLYCOSIDES//AMIKACIN//TOBRAMYCIN
5 0.0000158748 MARBOFLOXACIN//ENROFLOXACIN//DANOFLOXACIN
6 0.0000133123 CEFEPIME//CEFPIROME//FK037
7 0.0000117124 VANCOMYCIN//TEICOPLANIN//FUNCEI
8 0.0000112304 RUMINANT DIS EPIDEMIOL//SUCTION BLISTER METHOD//SKIN BLISTER FLUID CONCENTRATION
9 0.0000104423 CEFTAROLINE//CEFTOBIPROLE//CEFTOLOZANE TAZOBACTAM
10 0.0000092804 AMOXICILLIN SULBACTAM//SULTAMICILLIN//SULBACTAM